文献速递其他结缔组织病

iTr35细胞在系统性硬化症炎症反应与纤维化进展中的作用

The role of iTr35 cells in the inflammatory response and fibrosis progression of systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

本研究纳入68例系统性硬化症患者,检测iTr35与Tr1细胞亚群及IL-35、IL-10水平,并分析皮肤成纤维细胞纤维化相关基因与STAT3/6通路。结果显示iTr35细胞及IL-35升高而Tr1及IL-10降低,iTr35细胞可经STAT3/6通路影响α-SMA表达并抑制T细胞增殖分化,参与SSc炎症与纤维化。

要点

  • SSc患者外周血iTr35细胞比例升高、Tr1细胞降低,IL-35升高而IL-10降低。
  • SSc皮肤成纤维细胞EBI3、IL-12Ap35、Foxp3、IL-10降低,胶原I、TGF-β、α-SMA、纤连蛋白升高。
  • rhIL-35与rhIL-10共孵育时iTr35与Tr1细胞数多于单用任一细胞因子。

核心结论

  • iTr35和Tr1细胞均参与SSc相关炎症与纤维化,IL-35可诱导iTr35细胞并与IL-10产生协同效应。
  • iTr35细胞可通过STAT3/6信号通路抑制T细胞增殖与分化,从而引起纤维化。

研究设计与样本

  • 研究纳入68例系统性硬化症患者,采用流式细胞术检测iTr35与Tr1细胞亚群,ELISA检测IL-35与IL-10水平。
  • 采用免疫荧光、蛋白质印迹和免疫组织化学法检测iTr35、Tr1及纤维化相关基因与信号通路蛋白表达。

主要发现

  • 外周血iTr35细胞比例高于对照组,Tr1细胞低于对照组,IL-35表达升高而IL-10水平降低。
  • 皮肤组织成纤维细胞中EBI3、IL-12Ap35、Foxp3和IL-10表达降低,胶原I、TGF-β、α-SMA和纤连蛋白水平升高。
  • 磷酸化STAT3/6升高,而iTr35和Tr1细胞水平显著降低。
  • CD4+细胞与rhIL-35及rhIL-10共孵育时,iTr35和Tr1细胞数多于单用rhIL-35或单用rhIL-10处理的同类细胞。
  • 随iTr35细胞逐渐增加,常规CD4+ T细胞活力降低;iTr35细胞经STAT3/6信号通路影响α-SMA表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the role of induced immunosuppressive T regulatory (iTr) 35 cells in SSc-related inflammation and fibrosis. METHODS: Sixty-eight SSc patients were enrolled in this study. Subsets of iTr35 and Tr1 were measured by flow cytometry. IL-35 and IL-10 levels were measured using ELISA. Expressions of iTr35, Tr1, fibrosis-related genes and proteins associated with signalling pathways were determined using immunofluorescence, western blot and immunohistochemistry assays. RESULTS: In peripheral blood, the proportions of the iTr35 cells were higher and Tr1 cells were lower than the control group. Similarly, IL-35 expression was increased, while IL-10 levels were decreased. In fibroblasts from skin tissue, the expression levels of EBI3, IL-12Ap35, Foxp3 and IL-10 were decreased, but collagen I, TGF-β, alpha smooth muscle actin (α-SMA) and fibronectin levels were increased. Phosphorylated STAT3/6 were increased, but iTr35 and Tr1 cell levels were significantly decreased. When CD4+ cells were incubated with both recombinant human (rh)IL-35 and rhIL-10, the cell numbers of iTr35 and Tr1 were greater than the same type of cells treated with rhIL-35 or rhIL-10 alone. However, the viability of conventional CD4+ T cells was decreased by gradually increasing iTr35 cells. Moreover, iTr35 cells affected α-SMA expression through the STAT3/6 signalling pathway. CONCLUSION: Both iTr35 and Tr1 cells are involved in SSc-related inflammation and fibrosis. IL-35 can induce iTr35 cells, showing a synergistic effect with IL-10. We also found that iTr35 cells can inhibit T cell proliferation and differentiation via the STAT3/6 signalling pathway, thereby causing fibrosis.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Yang C, Lu C, Pan J, et al. The role of iTr35 cells in the inflammatory response and fibrosis progression of systemic sclerosis. Rheumatology (Oxford). 2023. PMID: 36734529. doi:10.1093/rheumatology/kead053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。